NEW YORK, April 26, 2010 (GLOBE NEWSWIRE) -- Nutra Pharma (OTCBB:NPHC), a Florida-based biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, will host a media & analyst conference.